Income Taxes	6 Months Ended
Jan. 01, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The effective tax rates for the second quarter and first six months of fiscal 2017 were 26.1% and (307.6)%, respectively, compared to 22.2% and 45.4% for the same respective periods last year. The effective tax rates for the second quarter and first six months of fiscal 2017 were primarily driven by the reversal of previously recorded reserves as the result of the effective settlement of the Company’s IRS audit for its fiscal year 2010 and 2013 consolidated income tax returns in the amount of approximately $3.9 million and the establishment of a valuation allowance against the deferred tax assets of the Company’s Brazilian subsidiary in the amount of approximately $2.7 million. The tax rates for the second quarter and first six months of fiscal 2016 were primarily impacted by the re-enactment of the U.S. research and development tax credit and losses incurred at certain foreign subsidiaries for which the Company does not receive tax benefits. For the six months ended January 1, 2017, the Company's unrecognized tax benefits decreased by $3.9 million, all of which impacted the current effective tax rate. Income tax returns are filed in the U.S., state, and foreign jurisdictions and related audits occur on a regular basis. In the U.S., the Company is no longer subject to U.S. federal income tax examinations before fiscal 2014. The Company is also currently under audit by various state and foreign jurisdictions. With respect to the Company's major foreign jurisdictions, they are no longer subject to tax examinations before fiscal 2006.

Income Taxes

6 Months Ended

Jan. 01, 2017

The effective tax rates for the second quarter and first six months of fiscal 2017 were 26.1% and (307.6)%, respectively, compared to 22.2% and 45.4% for the same respective periods last year. The effective tax rates for the second quarter and first six months of fiscal 2017 were primarily driven by the reversal of previously recorded reserves as the result of the effective settlement of the Company’s IRS audit for its fiscal year 2010 and 2013 consolidated income tax returns in the amount of approximately $3.9 million and the establishment of a valuation allowance against the deferred tax assets of the Company’s Brazilian subsidiary in the amount of approximately $2.7 million. The tax rates for the second quarter and first six months of fiscal 2016 were primarily impacted by the re-enactment of the U.S. research and development tax credit and losses incurred at certain foreign subsidiaries for which the Company does not receive tax benefits.

For the six months ended January 1, 2017, the Company's unrecognized tax benefits decreased by $3.9 million, all of which impacted the current effective tax rate.

Income tax returns are filed in the U.S., state, and foreign jurisdictions and related audits occur on a regular basis. In the U.S., the Company is no longer subject to U.S. federal income tax examinations before fiscal 2014. The Company is also currently under audit by various state and foreign jurisdictions. With respect to the Company's major foreign jurisdictions, they are no longer subject to tax examinations before fiscal 2006.